Showing results (31-40 of 715) with videos related to
Sort By:
Pageof 72
World Journal of Nuclear Medicine|January 15, 2020
Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted 18F-DCFPyL positron emission tomography/computed tomography: A unique visual patternYafu Yin, Channing J Paller, Martin G Pomper, et al.Tomography (Ann Arbor, Mich.)|December 28, 2020
Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold NanoparticlesMrudula Pullambhatla, Steven P Rowe, Ala Lisok, et al.AJR. American Journal of Roentgenology|October 6, 2021
Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the AJR Special Series on Imaging of InflammationSara Sheikhbahaei, Charles V Marcus, Mohammad S Sadaghiani, et al.EJNMMI Research|June 24, 2020
PET imaging of soluble epoxide hydrolase in non-human primate brain with [18F]FNDPYong Du, Il Minn, Catherine Foss, et al.Iscience|October 21, 2020
A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under HypoxiaEmmanuel Datan, Il Minn, Peng Xu, et al.Nuclear Medicine and Biology|May 4, 2024
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluationYutian Feng, Rebecca L Meshaw, Sean W Finch, et al.Journal of the American College of Radiology : JACR|May 28, 2019
From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal TrialsRudolf A Werner, Brent Savoie, Mehrbod S Javadi, et al.Annals of Translational Medicine|July 16, 2021
Narrative review of generative adversarial networks in medical and molecular imagingKazuhiro Koshino, Rudolf A Werner, Martin G Pomper, et al.Clinical Nuclear Medicine|September 25, 2015
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell CarcinomaSteven P Rowe, Michael A Gorin, Hans J Hammers, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate CancerSteven P Rowe, Alexander Drzezga, Bernd Neumaier, et al.Pageof 72